What is the latest medication on the market for restless leg syndrome?
Ethan Hayes
Published Jan 14, 2026
The FDA approved Horizant based on two 12-week studies done in adults. Those studies showed improvement in restless legs syndrome patients taking Horizant compared to those taking a placebo. Horizant's active ingredient is gabapentin enacarbil, which becomes gabapentin in the body.